| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 10,245,293 | 8,252,378 | 6,384,254 | | Cost of Revenue | 2,417,563 | 1,885,945 | 1,432,975 | | | Gross Profit | 7,827,730 | 6,366,433 | 4,951,279 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 2,539,966 | 2,084,115 | 1,636,704 | | Non Recurring |
-
|
-
|
-
| | Others | 2,084,272 | 1,548,472 | 1,180,839 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 3,203,492 | 2,733,846 | 2,133,736 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (555,443) | 157,158 | (290,724) | | Earnings Before Interest And Taxes | 2,724,025 | 2,963,669 | 1,843,012 | | Interest Expense | 153,341 | 134,581 | 177,145 | | Income Before Tax | 2,570,684 | 2,829,088 | 1,665,867 | | Income Tax Expense | 630,621 | 738,270 | 576,103 | | Minority Interest | (9,644) | (19,314) | (14,026) | | | | Net Income From Continuing Ops | 1,930,419 | 2,071,504 | 1,075,738 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 1,930,419 | 2,071,504 | 1,075,738 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,930,419 | $2,071,504 | $1,075,738 |
|
0.34% Nasdaq 0.00%
Income Statement
